Shu Zhang

Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice

Shuaijian Ni, N. Li, Zhenlin Zhang, 2022, Theranostics.

Drug discovery of sclerostin inhibitors

Shuaijian Ni, Zhenlin Zhang, Ge Zhang, 2022, Acta pharmaceutica Sinica. B.